Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1820 participants.

Also called NCT04893291

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,820 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04893291
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Bangladesh, Brazil, Brunei, France, Italy, Malaysia, Netherlands, Poland, Spain, Thailand, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04893291. Randomized; no masking; primary purpose treatment. Start 2021-11-16 (actual); primary completion 2026-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
Acronym
TRANSFORM II
Condition
Coronary Artery Stenosis
Intervention (Device)
Everolimus Eluting Stent
Intervention (Device)
Sirolimus Coated Balloon
Lead sponsor
Fondazione Ricerca e Innovazione Cardiovascolare ETS (class: other)

Record details

Record id
cardio:ct-nct04893291
Content hash
ca0fc2fb96f782418656152f2cedf2e198e0a8088a1f9828b4db010471021c56